DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q2 2020 13F-HR Holdings
Net value change ($000)
+282,774
(9.0%)
New positions
21
Sold out positions
20
Turnover %
30.1%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| HOLX | 78,101 | NEW |
| LRMR | 66,107 | NEW |
| SDGR | 65,222 | 112.4% |
| MyoKardia, Inc. | 51,780 | 318.8% |
| MERIDIAN BIOSCIENCE INC | 38,731 | NEW |
| IMMUNOMEDICS INC | 35,393 | 63.9% |
| PCRX | 32,687 | 59.9% |
| SpringWorks Therapeutics, Inc. | 30,556 | 143.6% |
| GBIO | 24,911 | NEW |
| RNAM | 24,784 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| AHCO | -252,830 | -91.9% |
| Horizon Therapeutics Public Ltd Co | -65,970 | -37.8% |
| QTTB | -62,740 | -100.0% |
| ABIOMED INC | -54,580 | -100.0% |
| AERIE PHARMACEUTICALS INC | -26,889 | -78.7% |
| TNDM | -26,568 | -100.0% |
| DXCM | -23,426 | -100.0% |
| Orchard Therapeutics plc | -23,173 | -34.7% |
| NTRA | -23,139 | -58.9% |
| SRPT | -22,988 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|